Featured Article
- Optimal pharmacotherapy to combat the atherogenic lipid triad.
- Prescription for publication. How to submit patient or physician attitudinal survey data to medical journals.
- Niacin and fibrates in atherogenic dyslipidemia: pharmacotherapy to reduce residual cardiovascular risk.
- The risks and hazards of interpreting and reporting health study measures. A simple, practical overview.
- Renal effects of COX-2 inhibitors.
- Public Awareness and Knowledge of Herpes Zoster: Results of a Global Survey.
- Safety, Tolerability, Pharmacokinetics, and Pharmacodynamic Properties of Taranabant, a Novel Selective Cannabinoid-1 Receptor Inverse Agonist, for the Treatment of Obesity
- Healthy food and healthy choices: a new European profile approach.
- Overview of the clinical development and results of a quadrivalent HPV (types 6, 11, 16, 18) vaccine.
- Clinical experience with the novel histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid) in patients with relapsed lymphoma.
- Dipeptidyl Peptidase-4 Inhibitors for the Treatment of Type 2 Diabetes: Focus On Sitagliptin.
- Caspofungin: an advanced treatment approach for suspected or confirmed invasive aspergillosis.
- Managing hypertension in cardiology practice according to risk profile.
